hydroquinidine has been researched along with cifenline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brembilla-Perrot, B; Gabriel, A; Lardoux, H; Levy, S; Marchand, X; Scheck, F; Touboul, P | 1 |
Allessie, MA; Dorland, R; Wijffels, MC | 1 |
Allessie, MA; Dorland, R; Mast, F; Wijffels, MC | 1 |
1 trial(s) available for hydroquinidine and cifenline
Article | Year |
---|---|
[Comparative effects of cibenzoline and hydroquinidine in the prevention of auricular fibrillation. A randomized double-blind study].
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Quinidine; Recurrence | 1995 |
2 other study(ies) available for hydroquinidine and cifenline
Article | Year |
---|---|
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Chronic Disease; Disease Models, Animal; Electrocardiography; Flecainide; Follow-Up Studies; Goats; Heart Conduction System; Imidazoles; Injections, Intravenous; Quinidine; Secondary Prevention; Sotalol; Treatment Outcome | 1999 |
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Goats; Heart Conduction System; Imidazoles; Quinidine; Sotalol | 2000 |